Invited speakers participate in the program to share their expert perspectives on clinical cancer research, technology, trials conduct and associated issues.
Speakers will be announced as they are confirmed.
Prof. Andre Dekker is a board-certified medical physicist at MAASTRO Clinic, Maastricht, The Netherlands since 2005. He has been the head of Medical Physics until 2009 and then led for numerous years the department of Information and Services that manages medical informatics and ICT. He is now responsible for all Research and Education activities at the hospital. He was appointed as a full professor at Maastricht University in 2015 where he holds the chair “Clinical Data Science”
From 2008, he started and is the principal investigator of the GROW-Maastricht University research division of MAASTRO Knowledge Engineering. His research focuses on two main themes: 1) global data sharing infrastructures; 2) machine learning on this data for decision support systems. The main scientific breakthrough has been the development of a Semantic Web and ontology based data sharing and distributed learning infrastructure that does not require data to leave the hospital. This has reduced many of the ethical and other barriers to share data.
Prof. Dekker has authored over 90 publications (h-index 37) in peer reviewed journals covering informatics, imaging, radiotherapy, tissue optics and heart disease and holds multiple awarded patents. He has held visiting scientist appointments at the Christie Hospital NHS trust; University of Sydney Australia; Liverpool and Macarthur Cancer therapy centres Australia; Illawarra Shoalhaven Local Health District Australia; Universita Cattolica Del Sacro Cuore, Italy; Radiation Therapy Oncology Group, USA, Varian Medical Systems, USA and the Princess Margaret Hospital in Canada.
Dr. Lee is currently the Vice Chair of the Department of Radiation Oncology at Memorial Sloan-Kettering Cancer Center focusing on Experimental Therapeutics. Nancy runs multiple international trials and is a major thought leader for head and neck cancer.
Nancy also serves as the medical director and president of the New York proton Center-NJ.
Dr. Lebovic has committed her career to the delivery of women's healthcare, with a special interest in the diagnosis and treatment of patients with breast cancer. Internationally recognized for her ground-breaking work as an Oncoplastic Surgeon, Dr. Lebovic is also highly regarded as a creative inventor and entrepreneur in the field of medical device development. At the 2014 World Congress of Breast Healthcare, she received the prestigious Pathfinder Lifetime Achievement Award, shared by well-known pioneers Professor Umberto Veronesi, Dr Laszlo Tabar and others. In addition to the Pathfinder Award, she has received the "Spirit of Achievement Award" from the American Cancer Society in 2012 recognizing her talents as a skilled clinician and her success as an innovator. Dr. Lebovic has served as Director of several important clinical programs, and has been active in philanthropy as evidenced by her position as past President of the American Society of Breast Disease. She is a passionate patient advocate, and commits much of her time to global educational projects in surgery and women's health. She currently holds the position of Chief Medical Officer at Focal Therapeutics, Inc.
The Royal Marsden NHS Foundation Trust, London, UK
Vincent Khoo is Clinical Oncologist at The Royal Marsden NHS Foundation Trust, Honorary Consultant at St George’s Hospital, and Honorary Senior Lecturer at the Institute of Cancer Research, University of London, London, UK.
Dr Khoo was previously Head of the Department of Clinical Oncology at The Royal Marsden Hospital. He has trained and worked in the UK, the USA, and Australia. He is an Adjunct Professor at the Department of Medical Imaging and Radiation Sciences, Monash University, and Honorary Associate Professor at the Department of Medicine, Melbourne University, and at Austin Health, Australia.
Dr Khoo specializes in urological cancers, with interests in systemic clinical trials, multimodality imaging, and technical radiotherapy from stereotactic to image-guided intensity-modulated and adaptive radiotherapy.
Dr Khoo has published over 250 papers and chapters, and is a member of several national and international committees, including the UK National Cancer Research Institute (NCRI) Clinical and Translational Radiotherapy Group, the National Cancer Research Network (NCRN) Prostate, Penile, and Kidney Clinical Studies Groups, the European SocieTy for Radiotherapy & Oncology (ESTRO), the European CanCer Organisation (ECCO) and European Society for Medical Oncology (ESMO).
Professor Oelfke is Deputy Head of the Division of Radiotherapy and Imaging, Head of the Joint Department of Physics (ICR and RMH) and Team Leader for the Radiotherapy Physics Modelling group. Professor Uwe Oelfke is combining recent developments in cancer biology, cancer therapeutics and medical physics in order to improve radiotherapy treatment and planning. Professor Oelfke has had a varied career spanning theoretical nuclear physics and finally medical physics.
Professor Pan graduated from Luzhou Medical College in 1982, receiving his bachelor’s degree. In 1985, Professor Pan started to pursue a master’s degree in Neurology at Shanghai Medical University and earned his MD degree with distinction in 1990. He then began working in the Neurosurgery Department of Huashan Hospital, Fudan University. Professor Pan also completed fellowships in Australia, the United States and Sweden. He won the title of Outstanding Youth of Shanghai, and was also awarded First Prize in the Fourth “Silver Snake Award” from Shanghai’s Health System.
Currently, Professor Pan serves as director of the Neurosurgery Department of Huashan Hospital and director of the CyberKnife Centre of Huashan Hospital as well as the vice president of the Shanghai Gamma Knife Hospital.
In addition, Professor Pan is the Deputy head of the Functional Neurosurgery Group of the Chinese Neurosurgical Society, the director of the Neuro-radiosurgery Expert Committee of the Chinese Association of Neurological Surgeons, and is an editorial board member of the Chinese Journal of Minimal Invasive Neurosurgery and other journals.
As one of the best known Chinese experts on CyberKnife and Gamma Knife, Professor Pan has tutored more than 10 postgraduates and MDs.
Major Research and Publications
Magnetic Resonance and CT guided Stereotactic Surgery Method and Directional Instrument Research, which won Third Prize for Scientific and Technological Achievements of the national Ministry of Health.
General-purpose Multifunction Stereotaxic Apparatus, which won First Prize for the WHO Excellent Paper Award.
Gamma Knife & Clinical Significance, which won Third Prize for Shanghai Scientific and Technological Achievements.
Professor Pan has published more than 80 scientific research papers, including nine published in internationally well-known journals such as the Journal of Neurosurgery, all included in SCI, and cited more than 30 times. He also took part in the writing of professional reference books such as Huang Jisi Surgery, Practical Surgery, Practical Neurosurgical Surgery, New Theory and New Technology of Oncology, New Theory and New Technology of Neurology, Graphic Neurosurgery, Modern Neurosurgery, and Clinical Diagnosis and Treatment Manual.